C. Angerstein

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

Thomas M. Behr, N Jenner, Martin Béhé et al. · PubMed · 1999 · 143 citations

Medicine, Oncology, Pharmacology +17

Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodies

Thomas M. Behr, Martin Béhé, Martin Löhr et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 113 citations

Pharmacy, Medicinal Chemistry, Radiology +16

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer

Thomas M. Behr, Torsten Liersch, Lutz Greiner-Bechert et al. · Cancer · 2002 · 111 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

Martin B�h�, Wolfgang Becker, Martin Gotthardt et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 77 citations

Natural Sciences, Chemistry, Nuclear Medicine +9

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.

Thomas M. Behr, Martin Béhé, C. Angerstein et al. · PubMed · 1999 · 61 citations

Medicine, Oncology, Pharmacology +15